Seroepidemiology of Herpes Simplex Virus Types 1 & 2 among HIV-Infected Patients Attending Clinic in Federal University Teaching Hospital, Owerri, Nigeria
International Journal of Global Health and Epidemiology · 2026
DOI: 10.54117/bz26w031 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Global Health and Epidemiology, 2026. Verfasst von Ikechukwu Ezekiel Emeka und 14 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Disease progression can be accelerated in patients who have HSV-1, HSV-2, or both. In this study, the seroepidemiology of HSV-1 and HSV-2 among HIV patients in Owerri, Imo State, Nigeria was investigated. A hospital-based cross-sectional study was conducted among HIV-positive patients attending the Heart-to-Heart unit of FUTHO between March and November 2025. Four hundred blood samples were reconfirmed for retroviral reactions using the Uni-Gold kits and screened for HSV types 1 and 2 using HSV-1/2 RDT kits. The CD4+ count was determined using the Human CD4+ ELISA kits. The socio-demographic data and risk factors were collected via questionnaires and analyzed using SPSS computer software, vs. 28. While all the blood samples were positive for HIV, the seroprevalence of HSV-1, HSV-2, and HSV-1 & 2 were 61%, 18.25%, and 17.5%, respectively. The results showed 58% (232/400) HSV-1 IgG, 3% (12/400) HSV-1 IgM, 16% (64/400) HSV-2 IgG, and 2.25% (9/400) IgM seropositive, respectively. The mean age of HIV patients screened for HSV was 40.12 years, with the highest prevalence recorded among people whose age was 41-50 years. Among patients on antiretroviral therapy for more than 2 years, 61%, 18.6%, and 17.9% were HSV-1, HSV-2, and HSV 1/2 positive, respectively, and those with CD4+ counts ≤ 500 cells/mm2 (HSV-1: 61.2%, HSV-2: 17.1%, HSV-1/2: 17.1%) exhibited high prevalence. Similar results were also observed in those with several sex partners (HSV-1:56.7%, HSV-2: 22.9%, HSV-1/2: 21.9%) and those who do not use condoms (HSV-1: 69.9%, HSV-2: 22.3%, HSV-1/2: 22.3%). There were more IgG seropositive samples than IgM for HSV-1 and 2. Community sensitization, with a strong emphasis on lifestyle changes, is recommended.
Zitieren
APA
Emeka, I. E., Chikwendu, C. I., Onyeukwu, U., Ekuma, Ujowundu, F. N., Okpu, H. A., Nna-Johnson, B. A., Abdulsalaam, N. O., Sanusi, G. O., John, E. I., Nwadili, B. K., Ugbarugba, O. S., Uwem, A. E., Umunna, V. C., & Ilemobayo, O. O. (2026). Seroepidemiology of Herpes Simplex Virus Types 1 & 2 among HIV-Infected Patients Attending Clinic in Federal University Teaching Hospital, Owerri, Nigeria. International Journal of Global Health and Epidemiology. https://doi.org/10.54117/bz26w031
Vancouver
Emeka IE, Chikwendu CI, Onyeukwu U, Ekuma, Ujowundu FN, Okpu HA, et al. Seroepidemiology of Herpes Simplex Virus Types 1 & 2 among HIV-Infected Patients Attending Clinic in Federal University Teaching Hospital, Owerri, Nigeria. International Journal of Global Health and Epidemiology. 2026. doi:10.54117/bz26w031
BibTeX
@article{Emeka2026,
author = {Emeka, Ikechukwu Ezekiel and Chikwendu, Chinwe Ifeyinwa and Onyeukwu, Uchechukwu and Ekuma and Ujowundu, Favour Ntite and Okpu, Hashimu Abubakar and Nna-Johnson, Benita Adangozi and Abdulsalaam, Nurudeen Olaitan and Sanusi, Grace Oluwabunmi and John, Emediong Ime and Nwadili, Bernard Kachi and Ugbarugba, Onome Sandra and Uwem, Aniefiok Essien and Umunna, Victoria Chinaza and Ilemobayo, Oluwaseun Oyeyemi},
title = {Seroepidemiology of Herpes Simplex Virus Types 1 & 2 among HIV-Infected Patients Attending Clinic in Federal University Teaching Hospital, Owerri, Nigeria},
journal = {International Journal of Global Health and Epidemiology},
year = {2026},
doi = {10.54117/bz26w031}
}
EUVIMED